Evaluation of 4D Vascular Flow and Tissue Perfusion in Cerebral Arteriovenous Malformations: Influence of Spetzler-Martin Grade, Clinical Presentation, and AVM Risk Factors

References

1. 1.↵
   2. Hernesniemi JA,
   3. Dashti R,
   4. Juvela S, et al

   . Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 2008;63:823–29; discussion 829–31

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Heidenreich JO,
   3. Hartlieb S,
   4. Stendel R, et al

   . Bleeding complications after endovascular therapy of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 2006;27:313–16

   Abstract/FREE Full Text
3. 3.↵
   2. Spetzler RF,
   3. Martin NA

   . A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Bammer R,
   3. Hope TA,
   4. Aksoy M, et al

   . Time-resolved 3D quantitative flow MRI of the major intracranial vessels: initial experience and comparative evaluation at 1.5T and 3.0T in combination with parallel imaging. Magn Reson Med 2007;57:127–40

   CrossRefPubMed
5. 5.↵
   2. Markl M,
   3. Frydrychowicz A,
   4. Kozerke S, et al

   . 4D flow MRI. J Magn Reson Imaging 2012;36:1015–36

   CrossRefPubMed
6. 6.↵
   2. Ansari SA,
   3. Schnell S,
   4. Carroll T, et al

   . Intracranial 4D flow MRI: toward individualized assessment of arteriovenous malformation hemodynamics and treatment-induced changes. AJNR Am J Neuroradiol 2013;34:1922–28

   Abstract/FREE Full Text
7. 7.↵
   2. Chang W,
   3. Loecher MW,
   4. Wu Y, et al

   . Hemodynamic changes in patients with arteriovenous malformations assessed using high-resolution 3D radial phase-contrast MR angiography. AJNR Am J Neuroradiol 2012;33:1565–72

   Abstract/FREE Full Text
8. 8.↵
   2. Hope MD,
   3. Purcell DD,
   4. Hope TA, et al

   . Complete intracranial arterial and venous blood flow evaluation with 4D flow MR imaging. AJNR Am J Neuroradiol 2009;30:362–66

   Abstract/FREE Full Text
9. 9.↵
   2. Srour JM,
   3. Shin W,
   4. Shah S, et al

   . SCALE-PWI: A pulse sequence for absolute quantitative cerebral perfusion imaging. J Cereb Blood Flow Metab 2011;31:1272–82

   CrossRefPubMed
10. 10.↵
    2. Carroll TJ,
    3. Horowitz S,
    4. Shin W, et al

    . Quantification of cerebral perfusion using the “bookend technique”: an evaluation in CNS tumors. Magn Reson Imaging 2008;26:1352–59

    CrossRefPubMed
11. 11.↵
    2. Mast H,
    3. Mohr JP,
    4. Osipov A, et al

    . ‘Steal’ is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke 1995;26:1215–20

    Abstract/FREE Full Text
12. 12.↵
    2. Bock J,
    3. Kreher BW,
    4. Hennig J, et al

    . Optimized pre-processing of time-resolved 2D and 3D phase contrast MRI data. In: Proceedings of the 15th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Berlin, Germany. May 19–25, 2007:3138
13. 13.↵
    2. Carroll TJ,
    3. Rowley HA,
    4. Haughton VM

    . Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003;227:593–600

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Guo WY,
    3. Wu YT,
    4. Wu HM, et al

    . Toward normal perfusion after radiosurgery: perfusion MR imaging with independent component analysis of brain arteriovenous malformations. AJNR Am J Neuroradiol 2004;25:1636–44

    Abstract/FREE Full Text
15. 15.↵
    2. Todaka T,
    3. Hamada J,
    4. Kai Y, et al

    . Analysis of mean transit time of contrast medium in ruptured and unruptured arteriovenous malformations: a digital subtraction angiographic study. Stroke 2003;34:2410–14

    Abstract/FREE Full Text
16. 16.↵
    2. Mohr JP,
    3. Parides MK,
    4. Stapf C, et al

    . Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614–21

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Ogasawara K,
    3. Yoshida K,
    4. Otawara Y, et al

    . Cerebral blood flow imaging in arteriovenous malformation complicated by normal perfusion pressure breakthrough. Surg Neurol 2001;56:380–84

    CrossRefPubMed
18. 18.↵
    2. Young WL,
    3. Prohovnik I,
    4. Ornstein E, et al

    . Monitoring of intraoperative cerebral hemodynamics before and after arteriovenous malformation resection. Anesth Analg 1988;67:1011–14

    PubMed
19. 19.↵
    2. Pollock BE,
    3. Flickinger JC,
    4. Lunsford LD, et al

    . Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke 1996;27:1–6

    Abstract/FREE Full Text
20. 20.↵
    2. Redekop G,
    3. TerBrugge K,
    4. Montanera W, et al

    . Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg 1998;89:539–46

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Stefani MA,
    3. Porter PJ,
    4. terBrugge KG, et al

    . Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 2002;33:1220–24

    Abstract/FREE Full Text
22. 22.↵
    2. Illies T,
    3. Forkert ND,
    4. Saering D, et al

    . Persistent hemodynamic changes in ruptured brain arteriovenous malformations. Stroke 2012;43:2910–15

    Abstract/FREE Full Text
23. 23.↵
    2. Raoult H,
    3. Ferre JC,
    4. Morandi X, et al

    . Quality-evaluation scheme for cerebral time-resolved 3D contrast-enhanced MR angiography techniques. AJNR Am J Neuroradiol 2010;31:1480–87

    Abstract/FREE Full Text
24. 24.↵
    2. Wolf RL,
    3. Wang J,
    4. Detre JA, et al

    . Arteriovenous shunt visualization in arteriovenous malformations with arterial spin-labeling MR imaging. AJNR Am J Neuroradiol 2008;29:681–87

    Abstract/FREE Full Text
25. 25.↵
    2. Fiehler J,
    3. Illies T,
    4. Piening M, et al

    . Territorial and microvascular perfusion impairment in brain arteriovenous malformations. AJNR Am J Neuroradiol 2009;30:356–61

    Abstract/FREE Full Text
26. 26.↵
    2. Nett EJ,
    3. Johnson KM,
    4. Frydrychowicz A, et al

    . Four-dimensional phase contrast MRI with accelerated dual velocity encoding. J Magn Reson Imaging 2012;35:1462–71

    CrossRefPubMed
27. 27.↵
    2. Jung B,
    3. Honal M,
    4. Ullmann P, et al

    . Highly k-t-space-accelerated phase-contrast MRI. Magn Reson Med 2008;60:1169–77

    CrossRefPubMed
28. 28.↵
    2. Vakil P,
    3. Lee JJ,
    4. Mouannes-Srour JJ, et al

    . Cerebrovascular occlusive disease: quantitative cerebral blood flow using dynamic susceptibility contrast MR imaging correlates with quantitative H2[15O] PET. Radiology 2013;266:879–86

    CrossRefPubMed
29. 29.↵
    2. Mukherjee P,
    3. Kang HC,
    4. Videen TO, et al

    . Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. AJNR Am J Neuroradiol 2003;24:862–71

    Abstract/FREE Full Text